Dopamine D2 Receptor Occupancy and Cognition in Schizophrenia: Analysis of the CATIE Data
Sakurai et al.
Schizophr Bull 2012;0:sbr189v1-sbr189.
ABSTRACT
| FULL TEXT
Distinct subclasses of medium spiny neurons differentially regulate striatal motor behaviors
Bateup et al.
Proc. Natl. Acad. Sci. USA 2010;107:14845-14850.
ABSTRACT
| FULL TEXT
Increased Synaptic Dopamine Function in Associative Regions of the Striatum in Schizophrenia
Kegeles et al.
Arch Gen Psychiatry 2010;67:231-239.
ABSTRACT
| FULL TEXT
Modeling the Effectiveness of Paliperidone ER and Olanzapine in Schizophrenia: Meta-Analysis of 3 Randomized, Controlled Clinical Trials
Ortega et al.
J Clin Pharmacol 2010;50:293-310.
ABSTRACT
| FULL TEXT
Resiliency of monoaminergic systems: the 80% rule and its relevance to drug development
Blier
J Psychopharmacol 2008;22:587-589.
In Vivo Inhibition of Serine Protease Processing Requires a High Fractional Inhibition of Cathepsin C
Methot et al.
Mol. Pharmacol. 2008;73:1857-1865.
ABSTRACT
| FULL TEXT
The role of emission tomography in pharmacokinetic and pharmacodynamic studies in clinical psychopharmacology
Malizia
J Psychopharmacol 2006;20:100-107.
ABSTRACT
Sensorimotor dysfunction of grasping in schizophrenia: a side effect of antipsychotic treatment?
Nowak et al.
J. Neurol. Neurosurg. Psychiatry 2006;77:650-657.
ABSTRACT
| FULL TEXT
Rational pharmacotherapy in early psychosis
REMINGTON
Br. J. Psychiatry 2005;187:s77-s84.
ABSTRACT
| FULL TEXT
Modern antipsychotic drugs: a critical overview
Gardner et al.
CMAJ 2005;172:1703-1711.
ABSTRACT
| FULL TEXT
D2 Receptor Occupancy During High- and Low-Dose Therapy with the Atypical Antipsychotic Amisulpride: A 123I-Iodobenzamide SPECT Study
la Fougere et al.
JNM 2005;46:1028-1033.
ABSTRACT
| FULL TEXT
Receptor Mechanisms in the treatment of Schizophrenia
Reynolds
J Psychopharmacol 2004;18:340-345.
ABSTRACT
Cerebral D2 and 5-HT2 Receptor occupancy in Schizophrenic Patients Treated with Olanzapine Or Clozapine
Moresco et al.
J Psychopharmacol 2004;18:355-365.
ABSTRACT
Mechanism of New Antipsychotic Medications: Occupancy Is Not Just Antagonism
Grunder et al.
Arch Gen Psychiatry 2003;60:974-977.
ABSTRACT
| FULL TEXT
Delayed Onset of Oculogyric Crisis and Torticollis with Intramuscular Haloperidol
Jhee et al.
The Annals of Pharmacotherapy 2003;37:1434-1437.
ABSTRACT
| FULL TEXT
High Levels of Serotonin Transporter Occupancy With Low-Dose Clomipramine in Comparative Occupancy Study With Fluvoxamine Using Positron Emission Tomography
Suhara et al.
Arch Gen Psychiatry 2003;60:386-391.
ABSTRACT
| FULL TEXT
Evaluation of EMD 128 130 occupancy of the 5-HT1A and the D2 receptor: a human PET study with [11]WAY-100635 and [11C]raclopride
Rabiner et al.
J Psychopharmacol 2002;16:195-199.
ABSTRACT
Striatal dopamine D2 receptor binding of risperidone in schizophrenic patients as assessed by 123I-iodobenzamide SPECT: a comparative study with olanzapine
Schmitt et al.
J Psychopharmacol 2002;16:200-206.
ABSTRACT
Extrastriatal and striatal D2 dopamine receptor blockade with haloperidol or new antipsychotic drugs in patients with schizophrenia
XIBERAS et al.
Br. J. Psychiatry 2001;179:503-508.
ABSTRACT
| FULL TEXT
The Role of Neuroimaging in Development of and Treatment With Antipsychotics
Verhoeff and Kapur
Journal of Pharmacy Practice 2001;14:332-340.
ABSTRACT
Choosing antipsychotic drugs in schizophrenia: A personal view
Bebbington
The Psychiatrist 2001;25:284-286.
FULL TEXT
Determining the optimal dose of haloperidol in first-episode psychosis
Oosthuizen et al.
J Psychopharmacol 2001;15:251-255.
ABSTRACT
Antipsychotic Drugs: Importance of Dopamine Receptors for Mechanisms of Therapeutic Actions and Side Effects
Strange
Pharmacol. Rev. 2001;53:119-134.
ABSTRACT
| FULL TEXT
An astroglia-linked dopamine D2-receptor action in prefrontal cortex
Khan et al.
Proc. Natl. Acad. Sci. USA 2001;98:1964-1969.
ABSTRACT
| FULL TEXT
Low dose typical antipsychotics - a brief evaluation
Taylor
The Psychiatrist 2000;24:465-468.
FULL TEXT
D2 receptor occupancy under recommended and high doses of olanzapine: an iodine-123-iodobenzamide SPECT study
Meisenzahl et al.
J Psychopharmacol 2000;14:364-370.
ABSTRACT
A Positron Emission Tomography Study of Quetiapine in Schizophrenia: A Preliminary Finding of an Antipsychotic Effect With Only Transiently High Dopamine D2 Receptor Occupancy
Kapur et al.
Arch Gen Psychiatry 2000;57:553-559.
ABSTRACT
| FULL TEXT
Intracellular Modulation of NMDA Receptor Function by Antipsychotic Drugs
Leveque et al.
J. Neurosci. 2000;20:4011-4020.
ABSTRACT
| FULL TEXT
Comparison of the Effects of Clozapine, Risperidone, and Olanzapine on Ketamine-Induced Alterations in Regional Brain Metabolism
Duncan et al.
J. Pharmacol. Exp. Ther. 2000;293:8-14.
ABSTRACT
| FULL TEXT
Atypical Antipsychotics and Dopamine D1 Receptor Agonism: An In Vivo Experimental Study Using Core Temperature Measurements in the Rat
Oerther and Ahlenius
J. Pharmacol. Exp. Ther. 2000;292:731-736.
ABSTRACT
| FULL TEXT
Long-Acting Antipsychotic Medication, Restraint and Treatment in the Management of Acute Psychosis
Fitzgerald
Aust N Z J Psychiatry 1999;33:660-666.
ABSTRACT
| FULL TEXT
Enhanced Cortical Dopamine Output and Antipsychotic-like Effects of Raclopride by 2 Adrenoceptor Blockade
Hertel et al.
Science 1999;286:105-107.
ABSTRACT
| FULL TEXT
Dopamine receptors, antipsychotic action and schizophrenia
Reynolds
J Psychopharmacol 1999;13:202-203.
Positron Emission Tomography Finding of a High Striatal D2Receptor Occupancy in Olanzapine-Treated Patients
Nordstrom et al.
Arch Gen Psychiatry 1998;55:283-284.
FULL TEXT
Delayed Normalization of Central D2 Dopamine Receptor Availability After Discontinuation of Haloperidol Decanoate: Preliminary Findings
Nyberg et al.
Arch Gen Psychiatry 1997;54:953-958.
ABSTRACT
D2 Dopamine Receptor Occupancy: A Crossover Comparison of Risperidone With Clozapine Therapy in Schizophrenic Patients
Su et al.
Arch Gen Psychiatry 1997;54:972-973.
ABSTRACT
In Vitro and In Vivo Characterization of the Dopamine D4 Receptor, Serotonin 5-HT2A Receptor and Alpha-1 Adrenoceptor Antagonist (R)-(+)-2-Amino-4-(4-Fluorophenyl)- 5-[1-[4-(4-Fluorophenyl)-4-Oxobutyl]Pyrrolidin-3-yl]Thiazole (NRA0045)
Okuyama et al.
J. Pharmacol. Exp. Ther. 1997;282:56-63.
ABSTRACT
| FULL TEXT
The Effects of a Selective D4 Dopamine Receptor Antagonist (L-745,870) in Acutely Psychotic Inpatients With Schizophrenia
Kramer et al.
Arch Gen Psychiatry 1997;54:567-572.
ABSTRACT
Dopamine D4 Receptor-Mediated Inhibition of Cyclic Adenosine 3',5'-Monophosphate Production Does Not Affect Prolactin Regulation
Sanyal and Van Tol
Endocrinology 1997;138:1871-1878.
ABSTRACT
| FULL TEXT
Atypical Antipsychotics and the Pharmacology of Olanzapine
Nihart
J Am Psychiatr Nurses Assoc 1997;3:S2-S7.
ABSTRACT
Psychopharmacological Profile of Amisulpride: An Antipsychotic Drug with Presynaptic D2/D3 Dopamine Receptor Antagonist Activity and Limbic Selectivity
Perrault et al.
J. Pharmacol. Exp. Ther. 1997;280:73-82.
ABSTRACT
| FULL TEXT
The Relationship Between Plasma Haloperidol Concentrations and Clinical Results
Palao et al.
Arch Gen Psychiatry 1996;53:1167-1168.
ABSTRACT
The Relationship Between Plasma Haloperidol Concentrations and Clinical Results-Reply
Volavka et al.
Arch Gen Psychiatry 1996;53:1168-1169.
ABSTRACT
Recent Advances: Psychiatry
Ramsay and Fahy
BMJ 1995;311:167-170.
FULL TEXT
Dopamine D2 Receptor Blockade and Antimigraine Action of Flunarizine
Wober et al.
Cephalalgia 1994;14:235-240.
ABSTRACT
Neuropsychological Deficits in Neuroleptic Naive Patients With First-Episode Schizophrenia
Saykin et al.
Arch Gen Psychiatry 1994;51:124-131.
ABSTRACT
Neuropharmacologic Basis for Clozapine's Unique Profile
Tandon and Kane
Arch Gen Psychiatry 1993;50:158-159.
ABSTRACT
Positron-emitting radioligands for studies in vivo-probes for human psychopharmacology
Pike
J Psychopharmacol 1993;7:139-158.
